The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Sanofi

  • SNY
  • NYSE
  • Consumer Products
  • Latest 51.63
  • Currency US$
  • Change -0.04
  • Percent Change -0.077 %
  • Volume 806,378
  • Fri Jul 11, 2014 04:02 PM EDT NYSE data delayed 15 minutes.
  • Open 51.45
  • Previous Close 51.67
  • High 51.95
  • Low 51.34
  • Bidx0 50.59
  • Askx0 53.75
  • 52-week High05/05 54.64
  • 52-week Low09/03 46.95
  • Beta 1.154
  • Market Cap 136,749.29M
  • EPS 2.26
  • P/E 22.845
  • Forward P/E 13.10
  • PEG 2.00
  • Annual Dividend 1.91
  • Yield 3.472

News

Financials & Calendars

Income Statement

  • Sales $44,506,640,000
  • Earnings $5,187,440,000
  • Return on Equity n/a

Cash Flow

  • Cash Flow --
  • Cash n/a
  • Current Ratio n/a

12 months ended Mar 31, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets n/a
  • Liabilities n/a
  • Liabilities-to-Equity Ratio n/a

Price Ratios

  • Price to Sales 3.07
  • Price to Book n/a
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Apr 29 $0.84 Jul 31 $0.79
Surprises Apr 29 -3.57% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Jul 14, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.

Related Securities
Symbol Type Latest % Chg

Officers

  • Christopher Viehbacher Chief Executive Officer;
  • David-Alexandre Executive Vice President
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

54 RUE LA BOETIE
PARIS, I0
75008


www.sanofi.com

Ideas & Discussion

Live Discussion of SNY on StockTwits